Ian Minns Clinical Oncology Society of Australia Annual Scientific Meeting 2017

Abstracts this author is presenting:

• Idronoxil levels of patients receiving NOX66 - an open label phase 1a PK study — Poster Session 1
• ENOX2 levels of patients receiving NOX66 in an open label phase 1a PK Study — Poster Session 1
• Safety of NOX66 in combination with palliative dose radiotherapy – a phase 1 dose escalation study — Poster Session 1